Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: Demand, supply and seasonality

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Lorick, Suchita A ^a,b   Fishbein, Daniel ^a,c   Weintraub, Eric ^b   Wortley, Pascale M ^a   Lee, Grace M ^d   Zhou, Fangjun ^a   Davis, Robert ^b,e  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL CENTER FOR PREPAREDNESS DETECTION AND CONTROL OF INFECTIOUS DISEASES   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TETANUS VACCINE; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE; VACCINE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DRUG UPTAKE; GROUPS BY AGE; HUMAN; INFECTION RISK; MANAGED CARE ORGANIZATION; POST HOC ANALYSIS; SCHOOL CHILD; SEASONAL VARIATION; SUMMER; UNITED STATES; CLINICAL TRIAL; HEALTH INSURANCE; IMMUNIZATION; MULTICENTER STUDY; PREVENTIVE HEALTH SERVICE; SEASON; STATISTICS; UTILIZATION REVIEW; VACCINATION;

ADOLESCENT; DIPHTHERIA-TETANUS VACCINE; HUMANS; IMMUNIZATION PROGRAMS; IMMUNIZATION, SECONDARY; MANAGED CARE PROGRAMS; MENINGOCOCCAL VACCINES; SEASONS; UNITED STATES; VACCINATION; VACCINES, CONJUGATE;

EID: 73949091648     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-175     Document Type: Article

References (30)

1. Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2005, 27;54(RR-7):1-21.
2. Centers for Disease Control and Prevention Record of the Meeting of the Advisory Committee on Immunization Practices. Centers for Disease Control and Prevention 2005 February 10. Accessed Feb 26 2008, Centers for Disease Control and Prevention., http://www.cdc.gov/vaccines/recs/ACIP/downloads/min-archive/min-feb05.rt f
3. Meningococcal disease and college students Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000, 30;49(RR-7):13-20. Meningococcal disease and college students.
4. Statement regarding the availability of Menactra vaccine. Sanofi Pasteur SA 2005 July 19. Accessed Feb 28 2008., http://www.acha.org/sanofi_pasteur_7-19-05.pdf
5. Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June-July 2005. MMWR Morb Mortal Wkly Rep 2005, 14;54(40):1023-5.
6. Destefano F. The Vaccine Safety Datalink project. Pharmacoepidemiol Drug Saf 2001, 10(5):403-6. 10.1002/pds.613, 11802585.
7. Centers for Disease Control and Prevention Immunization of adolescents. Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association. MMWR Morb Mortal Wkly Rep 1996, 22;45(RR-13):1-16. Centers for Disease Control and Prevention.
8. Gonzalez IM, Averhoff FM, Massoudi MS, Yusuf H, Destefano F, Kramarz P, Maher JE, Mullooly JP, Chun C, Davis RL, et al. Hepatitis B vaccination among adolescents in 3 large health maintenance organizations. Pediatrics 2002, 110(5):929-34. 10.1542/peds.110.5.929, 12415032.
9. Mell LK, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, Ward JI, Marcy SM, Chen RT. Polio extraimmunization in children younger than 2 years after changes in immunization recommendations. Pediatrics 2003, 111(2):296-301. 10.1542/peds.111.2.296, 12563054.
10. Rapid assessment of influenza vaccination coverage among HMO members--northern California influenza seasons, 2001-02 through 2004-05. MMWR Morb Mortal Wkly Rep 2005, 15;54(27):676-8.
11. Rotavirus vaccination coverage and adherence to the Advisory Committee on Immunization Practices (ACIP)-recommended vaccination schedule--United States, February 2006-May 2007. MMWR Morb Mortal Wkly Rep 2008, 18;57(15):398-401.
12. Lieu TA, Kulldorff M, Davis RL, Lewis EM, Weintraub E, Yih K, Yin R, Brown JS, Platt R. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care 2007, 45(10 Supl 2):S89-S95. 10.1097/MLR.0b013e3180616c0a, 17909389.
13. U.S.Census Bureau PDE&SSB School Enrollment--Social and Economic Characteristics of Students: October 2005. US Census Bureau 2007 November 8. Accessed Feb 28 2008, U.S.Census Bureau PDE&SSB., http://www.census.gov/population/www/socdemo/school/cps2005.html
14. National vaccination coverage among adolescents aged 13-17 years--United States, 2006. MMWR Morb Mortal Wkly Rep 2007, 31;56(34):885-8.
15. Fogarty KJ, Massoudi MS, Gallo W, Averhoff FM, Yusuf H, Fishbein D. Vaccine coverage levels after implementation of a middle school vaccination requirement, Florida, 1997-2000. Public Health Rep 2004, 119(2):163-9. 1497615, 15192903.
16. Averhoff F, Linton L, Peddecord KM, Edwards C, Wang W, Fishbein D. A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health 2004, 94(6):978-84. 1448376, 15249302, 10.2105/AJPH.94.6.978.
17. Wilson T. Economic evaluation of a metropolitan-wide, school-based hepatitis B vaccination program. Public Health Nurs 2000, 17(3):222-7. 10.1046/j.1525-1446.2000.00222.x, 10840293.
18. Wilson TR, Fishbein DB, Ellis PA, Edlavitch SA. The impact of a school entry law on adolescent immunization rates. J Adolesc Health 2005, 37(6):511-6. 10.1016/j.jadohealth.2005.07.009, 16310129.
19. Middleman AB, Robertson LM, Young C, Durant RH, Emans SJ. Predictors of time to completion of the hepatitis B vaccination series among adolescents. J Adolesc Health 1999, 25(5):323-7. 10.1016/S1054-139X(99)00063-4, 10551662.
20. Klein JD, Allan MJ, Elster AB, Stevens D, Cox C, Hedberg VA, Goodman RA. Improving Adolescent Preventive Care in Community Health Centers. Pediatrics 2001, 107(2):318-27. 10.1542/peds.107.2.318, 11158465.
21. Enger KS, Stokley S. Meningococcal conjugate vaccine uptake, measured by Michigan's immunization registry. J Adolesc Health 2007, 40(5):398-404. 10.1016/j.jadohealth.2006.11.141, 17448396.
22. McCauley M, Stokley S, Stevenson J, Fishbein D. Immunization: What happens at healthcare visits for adolescents at ages 11-12? National Health Interview Survey 1997-2003 (Abstract 55541.226). Pediatric Academic Societies 2006,
23. Baughman AL, Williams WW, Atkinson WL, Cook LG, Collins M. The impact of college prematriculation immunization requirements on risk for measles outbreaks. JAMA 1994, 12;272(14):1127-32.
24. Centers for Disease Control and Prevention Childcare and School Immunization Requirements 2005-2006. Centers for Disease Control and Prevention 2007 June 4. Accessed Feb 26 2008, Centers for Disease Control and Prevention., http://www.cdc.gov/vaccines/vac-gen/laws/downloads/izlaws05-06.pdf
25. Centers for Disease Control and Prevention Record of the Meeting of the Advisory Committee on Immunization Practices. Centers for Disease Control and Prevention 2005 February 10. Accessed Feb 26 2008, Centers for Disease Control and Prevention., http://www.cdc.gov/vaccines/recs/ACIP/downloads/min-archive/min-feb05.rt f
26. Centers for Disease Control and Prevention Record of the Meeting of the Advisory Committee on Immunization Practices. Centers for Disease Control and Prevention 2005 February 10. Accessed Feb 26 2008, Centers for Disease Control and Prevention., http://www.cdc.gov/vaccines/recs/ACIP/downloads/min-archive/min-feb05.rt f
27. Centers for Disease Control and Prevention Record of the Meeting of the Advisory Committee on Immunization Practices. Centers for Disease Control and Prevention 2006 June 29. Accessed Sep 2 2008, Centers for Disease Control and Prevention., http://www.cdc.gov/vaccines/recs/ACIP/downloads/min-jun06.txt
28. Centers for Disease Control and Prevention Notice to Readers: Improved Supply of Meningococcal Conjugate Vaccine, Recommendation to Resume Vaccination of Children Aged 11--12 Years. MMWR Morb Mortal Wkly Rep 2006, 3;55:1177. Centers for Disease Control and Prevention.
29. Centers for Disease Control and Prevention Notice to readers. Limited supply of meningococcal conjugate vaccine, recommendations to defer vaccination of persons age 11-12 years. MMWR Morb Mortal Wkly Rep 2006, 19;55(20):567-8. Centers for Disease Control and Prevention.
30. Centers for Disease Control and Prevention Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine. MMWR Morb Mortal Wkly Rep 2007, 10;56(31):794-5. Centers for Disease Control and Prevention.